AskBio Inc

Quick facts

Phase 2 pipeline

• AB-1002 · Genetic disorders
  AB-1002 is a gene therapy that aims to treat certain genetic disorders by delivering a healthy copy of the gene.
• AB-1005

Phase 1 pipeline

• ACTUS-101

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AskBio Inc portfolio CI brief
• AskBio Inc pipeline updates RSS